Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-10

Clinical Trial Update: An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2

View source ↗

Summary

An observational study of alogliptin benzoate in adults with type 2 diabetes mellitus has been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin benzoate (alogliptin benzoate)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Status: COMPLETED | Results posted: 2019-07-10